Alignment Healthcare, Inc.
For the period ended Sep 30, 2025. Filed Oct 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 30, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Rule 10b5-1 Plans
During the fiscal quarter ended September 30, 2025, our executive officers and directors adopted or terminated, as applicable, the following trading arrangements that are intended to satisfy the affirmative defense of Rule 10b5-1(c):
| Name & Title | Date of Adoption | Date of Termination | Duration of Trading Arrangement | Maximum Number of Securities to be Sold(1) |
|---|---|---|---|---|
| Christopher Joyce, Chief Legal & Administrative Officer | 9/8/2025 | N/A | 12/8/2025 – 9/11/2026 | 95,455 |
(1)Securities reported in this column include securities subject to limit orders and such orders may not fill if limit order conditions are not met. The actual number of shares sold under the plan will depend on the vesting of certain performance-based equity awards and the number of shares withheld or sold satisfy our income tax withholding obligations and may vary from the number provided herein. The number of performance share units included in plans assumes awards are earned at target.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.